Robotic-assisted lung resection for malignant disease

Casandra A. Anderson, Minia Hellan, Andres Falebella, Clayton S. Lau, Fredric W. Grannis, Kemp H. Kernstine

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

OBJECTIVE: There have been few reports of the use of robotic surgery to resect lung malignancies. Feasibility and safety of robotic lung resection for malignant lung lesions will be assessed by performing a retrospective analysis. METHODS: Between September 2004 and November 2006, 21 patients (11 male and 10 female patients) underwent robotic lung resection. Twenty resections were performed for primary nonsmall cell lung cancer and two for metastatic lesions. One patient had bilateral resections for two primary tumors. Fourteen lobectomies, five segementectomies, one wedge resection, and two bilobectomies were performed. Seventy-two percent of operative procedures included mediastinoscopy and/or bronchoscopy at the time of resection. RESULTS: Thirty-day mortality and conversion rate was 0%. The median operating room time and estimated blood loss was 3.6 hours and 100 mL, respectively. The median intensive care unit and total length of hospital stays were 2 and 4 days, respectively. Chest tubes were removed after a median of 2.0 days. The complication rate was 27%, which included atrial fibrillation, need for postoperative bronchoscopy, and pneumonia. The median tumor size and number of lymph nodes harvested was 2.3 cm and 16, respectively. All resection margins were negative. Median follow-up time was 9.8 months, with no local recurrences at this time. CONCLUSION: Robotic lung resection appears safe and feasible and allows for significant lymph node retrieval, offers short hospital stays and low morbidity for patients undergoing surgical resection of lung malignancies. Future studies are needed to define the role of robotic surgery in lung cancer treatment.

Original languageEnglish (US)
Pages (from-to)254-258
Number of pages5
JournalInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Volume2
Issue number5
DOIs
StatePublished - Sep 2007

Fingerprint

Robotics
Lung
Length of Stay
Bronchoscopy
Neoplasms
Lymph Nodes
Mediastinoscopy
Chest Tubes
Operative Surgical Procedures
Operating Rooms
Non-Small Cell Lung Carcinoma
Atrial Fibrillation
Intensive Care Units
Lung Neoplasms
Pneumonia
Morbidity
Safety
Recurrence
Mortality

Keywords

  • Lung cancer
  • Minimally invasive lung resection
  • Robotic lobectomy
  • Robotic technology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Robotic-assisted lung resection for malignant disease. / Anderson, Casandra A.; Hellan, Minia; Falebella, Andres; Lau, Clayton S.; Grannis, Fredric W.; Kernstine, Kemp H.

In: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, Vol. 2, No. 5, 09.2007, p. 254-258.

Research output: Contribution to journalArticle

Anderson, Casandra A. ; Hellan, Minia ; Falebella, Andres ; Lau, Clayton S. ; Grannis, Fredric W. ; Kernstine, Kemp H. / Robotic-assisted lung resection for malignant disease. In: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2007 ; Vol. 2, No. 5. pp. 254-258.
@article{a796b59e8a9a454c8b8222f7934754a7,
title = "Robotic-assisted lung resection for malignant disease",
abstract = "OBJECTIVE: There have been few reports of the use of robotic surgery to resect lung malignancies. Feasibility and safety of robotic lung resection for malignant lung lesions will be assessed by performing a retrospective analysis. METHODS: Between September 2004 and November 2006, 21 patients (11 male and 10 female patients) underwent robotic lung resection. Twenty resections were performed for primary nonsmall cell lung cancer and two for metastatic lesions. One patient had bilateral resections for two primary tumors. Fourteen lobectomies, five segementectomies, one wedge resection, and two bilobectomies were performed. Seventy-two percent of operative procedures included mediastinoscopy and/or bronchoscopy at the time of resection. RESULTS: Thirty-day mortality and conversion rate was 0{\%}. The median operating room time and estimated blood loss was 3.6 hours and 100 mL, respectively. The median intensive care unit and total length of hospital stays were 2 and 4 days, respectively. Chest tubes were removed after a median of 2.0 days. The complication rate was 27{\%}, which included atrial fibrillation, need for postoperative bronchoscopy, and pneumonia. The median tumor size and number of lymph nodes harvested was 2.3 cm and 16, respectively. All resection margins were negative. Median follow-up time was 9.8 months, with no local recurrences at this time. CONCLUSION: Robotic lung resection appears safe and feasible and allows for significant lymph node retrieval, offers short hospital stays and low morbidity for patients undergoing surgical resection of lung malignancies. Future studies are needed to define the role of robotic surgery in lung cancer treatment.",
keywords = "Lung cancer, Minimally invasive lung resection, Robotic lobectomy, Robotic technology",
author = "Anderson, {Casandra A.} and Minia Hellan and Andres Falebella and Lau, {Clayton S.} and Grannis, {Fredric W.} and Kernstine, {Kemp H.}",
year = "2007",
month = "9",
doi = "10.1097/IMI.0b013e31815e52f1",
language = "English (US)",
volume = "2",
pages = "254--258",
journal = "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery",
issn = "1556-9845",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Robotic-assisted lung resection for malignant disease

AU - Anderson, Casandra A.

AU - Hellan, Minia

AU - Falebella, Andres

AU - Lau, Clayton S.

AU - Grannis, Fredric W.

AU - Kernstine, Kemp H.

PY - 2007/9

Y1 - 2007/9

N2 - OBJECTIVE: There have been few reports of the use of robotic surgery to resect lung malignancies. Feasibility and safety of robotic lung resection for malignant lung lesions will be assessed by performing a retrospective analysis. METHODS: Between September 2004 and November 2006, 21 patients (11 male and 10 female patients) underwent robotic lung resection. Twenty resections were performed for primary nonsmall cell lung cancer and two for metastatic lesions. One patient had bilateral resections for two primary tumors. Fourteen lobectomies, five segementectomies, one wedge resection, and two bilobectomies were performed. Seventy-two percent of operative procedures included mediastinoscopy and/or bronchoscopy at the time of resection. RESULTS: Thirty-day mortality and conversion rate was 0%. The median operating room time and estimated blood loss was 3.6 hours and 100 mL, respectively. The median intensive care unit and total length of hospital stays were 2 and 4 days, respectively. Chest tubes were removed after a median of 2.0 days. The complication rate was 27%, which included atrial fibrillation, need for postoperative bronchoscopy, and pneumonia. The median tumor size and number of lymph nodes harvested was 2.3 cm and 16, respectively. All resection margins were negative. Median follow-up time was 9.8 months, with no local recurrences at this time. CONCLUSION: Robotic lung resection appears safe and feasible and allows for significant lymph node retrieval, offers short hospital stays and low morbidity for patients undergoing surgical resection of lung malignancies. Future studies are needed to define the role of robotic surgery in lung cancer treatment.

AB - OBJECTIVE: There have been few reports of the use of robotic surgery to resect lung malignancies. Feasibility and safety of robotic lung resection for malignant lung lesions will be assessed by performing a retrospective analysis. METHODS: Between September 2004 and November 2006, 21 patients (11 male and 10 female patients) underwent robotic lung resection. Twenty resections were performed for primary nonsmall cell lung cancer and two for metastatic lesions. One patient had bilateral resections for two primary tumors. Fourteen lobectomies, five segementectomies, one wedge resection, and two bilobectomies were performed. Seventy-two percent of operative procedures included mediastinoscopy and/or bronchoscopy at the time of resection. RESULTS: Thirty-day mortality and conversion rate was 0%. The median operating room time and estimated blood loss was 3.6 hours and 100 mL, respectively. The median intensive care unit and total length of hospital stays were 2 and 4 days, respectively. Chest tubes were removed after a median of 2.0 days. The complication rate was 27%, which included atrial fibrillation, need for postoperative bronchoscopy, and pneumonia. The median tumor size and number of lymph nodes harvested was 2.3 cm and 16, respectively. All resection margins were negative. Median follow-up time was 9.8 months, with no local recurrences at this time. CONCLUSION: Robotic lung resection appears safe and feasible and allows for significant lymph node retrieval, offers short hospital stays and low morbidity for patients undergoing surgical resection of lung malignancies. Future studies are needed to define the role of robotic surgery in lung cancer treatment.

KW - Lung cancer

KW - Minimally invasive lung resection

KW - Robotic lobectomy

KW - Robotic technology

UR - http://www.scopus.com/inward/record.url?scp=37349094036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349094036&partnerID=8YFLogxK

U2 - 10.1097/IMI.0b013e31815e52f1

DO - 10.1097/IMI.0b013e31815e52f1

M3 - Article

C2 - 22437136

AN - SCOPUS:37349094036

VL - 2

SP - 254

EP - 258

JO - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

JF - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

SN - 1556-9845

IS - 5

ER -